In 2026, Medicare-linked survey data establish the size, cost, and underreporting of dementia, while routine coverage of new blood tests stays uncertain. Medicare-linked means researchers join survey answers to Medicare billing records to compare what people report with what claims show.
That link matters for adults with memory concerns and caregivers. The Alzheimer's Association counts 7.4 million Americans age 65 and older living with Alzheimer's dementia in 2026 in its 2026 Facts and Figures. That is about one in nine in that age group.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Official resources:
- Read the original report from Yale — Use this primary source to review the complete report.
- Read the original report from Alz — Use this primary source to review the complete report.
Table of Contents
- Who do these surveys track
- Why does cost shape data priorities
- Why does dementia go unreported in surveys
- What support is already being tested
- What is still uncertain about early tests
Who do these surveys track
Researchers built the core 2026 finding from the Health and Retirement Study joined to Medicare billing records from 1998 through 2020. The Health and Retirement Study is a long-running survey of older Americans. Validated cognitive testing defined probable dementia, which means test results point to dementia.
They compared the claims wave with self-report from the same period. That design tests whether a Medicare-claims dementia diagnosis appears in the person's own survey answer. It keeps the focus on self-responding older adults, not proxy answers.
Why does cost shape data priorities
The Alzheimer's Association projects $409 billion in health and long-term care costs for Alzheimer's and other dementias in 2026. Medicare and Medicaid cover $263 billion, or 64 percent. Families pay $103 billion out of pocket.
Those shares explain why Medicare surveys track service use, caregiver strain, and bills. Cost pressure falls on public programs and households at the same time. Families can use the split to plan for medical bills, home help, and time off work.
Why does dementia go unreported in surveys
Yale News describes self-responding older adults with probable dementia and a Medicare-claims diagnosis. In that group, 67% said no doctor ever told them they had dementia in the Yale diagnosis study. The same people underreported hypertension at 23% and arthritis at 17%.
Memory loss, stigma, and poor disclosure can block recall of being told. Yale researchers note that a missing self-report plus a claims code does not prove the talk never happened. Readers should treat non-report as a signal to confirm, not proof of failure.
What support is already being tested
CMS started the voluntary GUIDE model on July 1, 2024, for eight years to help dementia patients stay home. The model pays for care navigation, caregiver education, round-the-clock support, and respite for eligible Traditional Medicare beneficiaries, CMS says in the GUIDE launch summary.
Ask a clinic whether it joins GUIDE. Written notes reduce reliance on memory after a hard visit. A second listener helps catch next steps and support options.
- Bring a trusted person and a dated list of memory changes
- Ask for the diagnosis in plain words and a written visit note
- Ask what home support and respite your site offers
What is still uncertain about early tests
Routine Medicare coverage of FDA-cleared Alzheimer's blood tests remains uncertain. The Alzheimer's Association says the bipartisan ASAP Act would create a coverage path for early detection. The bill drew 90% voter support for coverage and House Ways and Means action, but it is not yet law. National survey results show the demand.
The Alzheimer's Association April 2026 report news says 99% of adults 40 and older call brain health as important as physical health. Only 9% say they know how to maintain it, and over two-thirds worry about dementia. Ask your clinician what test fits your symptoms, what it costs today, and how results would change care. Bring a written list of memory changes and ask whether an FDA-cleared test fits your case while rules evolve.
You Might Also Like
- Food Access and Brain Health Research Priorities in 2026: Research Participation Questions for Adults With Memory Concerns
- Dementia With Multiple Etiologies in the 2026 NIA Report: Study Design and Evidence Limits for Adults With Memory Concerns
- Tauklarify Tau PET vs Alzheimer’s Blood Tests in 2026: Access, Cost, and Follow-Up Questions for Adults With New Memory Symptoms
